These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Potential utility of sentinel node biopsy in the original surgical assessment of Hürthle cell tumors of the thyroid: 23-year institutional review of Hürthle cell neoplasms. Johnson LW, Sehon J, Li BD. J Surg Oncol; 1999 Feb; 70(2):100-2. PubMed ID: 10084652 [Abstract] [Full Text] [Related]
63. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI. Cancer; 2003 Mar 01; 97(5):1186-94. PubMed ID: 12599224 [Abstract] [Full Text] [Related]
64. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma. Mai KT, Khanna P, Yazdi HM, Perkins DG, Veinot JP, Thomas J, Lamba M, Nair BD. Pathology; 2002 Jun 01; 34(3):239-44. PubMed ID: 12109784 [Abstract] [Full Text] [Related]
65. Report of a hürthle cell neoplasm in a peripubertal girl. Bremer AA, Feldman BJ, Iezza G, Clark OH, Rosenthal SM. Thyroid; 2007 Feb 01; 17(2):175-8. PubMed ID: 17316121 [Abstract] [Full Text] [Related]
67. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology. Yazgan A, Balci S, Dincer N, Kiyak G, Tuzun D, Ersoy R, Cakir B, Guler G. Cytopathology; 2014 Jun 01; 25(3):185-9. PubMed ID: 24024935 [Abstract] [Full Text] [Related]
68. Recurrent Hurthle cell thyroid carcinoma does not preclude long-term survival: a case report and review of the literature. Blossey RD, Kleine-Döpke D, Ringe KI, Pöhnert D, Ringe B, Klempnauer J, Beetz O. J Med Case Rep; 2021 Aug 11; 15(1):399. PubMed ID: 34376229 [Abstract] [Full Text] [Related]
69. Surgical treatment of Hurthle cell tumors of the thyroid. Chao TC, Lin JD, Chen MF. World J Surg; 2005 Feb 11; 29(2):164-8. PubMed ID: 15650796 [Abstract] [Full Text] [Related]
70. Cytology of Hürthle cell neoplasms of thyroid gland. Hemachandran M, Rajwanshi A, Srinivasan R, Nijhawan R, Radotra BD. Indian J Pathol Microbiol; 2007 Oct 11; 50(4):859-61. PubMed ID: 18306589 [Abstract] [Full Text] [Related]
75. Genetics, Diagnosis, and Management of Hürthle Cell Thyroid Neoplasms. McFadden DG, Sadow PM. Front Endocrinol (Lausanne); 2021 Oct 11; 12():696386. PubMed ID: 34177816 [Abstract] [Full Text] [Related]
76. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy. Ha EJ, Baek JH, Lee JH, Song DE, Kim JK, Shong YK, Hong SJ. Thyroid; 2013 Jun 11; 23(6):703-8. PubMed ID: 23544697 [Abstract] [Full Text] [Related]
77. Solitary fibrous tumor of the thyroid gland: a report of two cases with an analysis of their clinical and pathological features. Verdi D, Pennelli G, Pelizzo MR, Toniato A. Endocr Pathol; 2011 Sep 11; 22(3):165-9. PubMed ID: 21818669 [Abstract] [Full Text] [Related]
78. Oncocytic Change in Thyroid Pathology. Asa SL, Mete O. Front Endocrinol (Lausanne); 2021 Sep 11; 12():678119. PubMed ID: 34012422 [Abstract] [Full Text] [Related]
79. Clinical images. Solitary fibrous tumor of the perithyroidal soft tissue mimicking substernal goiter. Sevinc AI, Canda AE, Unek T, Canda S, Kocdor MA, Saydam S, Harmancioglu O. Am J Surg; 2010 Jun 11; 199(6):e82-3. PubMed ID: 20609717 [Abstract] [Full Text] [Related]